Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/27/2025

Management of Tinea Corporis

Diagnostic Confirmation

  • The American Academy of Dermatology recommends obtaining potassium hydroxide (KOH) preparation or fungal culture before initiating treatment to confirm dermatophyte infection and identify the causative organism 2
  • Culture specimens on Sabouraud agar if KOH is negative but clinical suspicion remains high, as recommended by the British Association of Dermatologists 3

First-Line Topical Therapy

  • The American College of Dermatology recommends topical terbinafine 1% cream applied once daily for 1-2 weeks as first-line therapy for localized tinea corporis 1, 2
  • Alternative topical options include naftifine 1% once daily for 1-2 weeks, as suggested by the American Academy of Dermatology 1

Oral Antifungal Therapy

  • The Infectious Diseases Society of America recommends systemic therapy for extensive or large body surface area infections, treatment failure, or immunocompromised patients 1, 2
  • The American Academy of Pediatrics recommends terbinafine 250 mg daily for 1-2 weeks, achieving an 87.1% mycological cure rate 4, 5, 2
  • The American College of Dermatology recommends itraconazole 100 mg daily for 15 days, achieving an 87% mycological cure rate 4, 5, 1

Treatment Monitoring and Endpoints

  • The American Academy of Dermatology recommends mycological cure (negative microscopy and culture) as the definitive treatment endpoint 1, 2
  • Repeat mycology sampling at the end of standard treatment period and continue monthly until mycological clearance is documented, as suggested by the American College of Dermatology 1

Prevention of Recurrence

  • The Centers for Disease Control and Prevention recommend screening and treating all household contacts, as over 50% may be affected with anthropophilic species like T. tonsurans 2
  • The American Academy of Pediatrics recommends cleaning all fomites (combs, brushes, towels, clothing) with disinfectant or 2% sodium hypochlorite solution 4, 5
  • The American College of Dermatology recommends applying antifungal powders (miconazole, clotrimazole, tolnaftate) to prevent reinfection in high-risk individuals 1

Special Considerations and Pitfalls

  • The American Heart Association recommends avoiding itraconazole in heart failure due to significant drug interactions 1
  • The American College of Dermatology recommends baseline liver function tests before initiating oral terbinafine or itraconazole, especially with pre-existing hepatic abnormalities 1
  • The British Association of Dermatologists recommends terbinafine for Trichophyton species and griseofulvin for Microsporum species if organism-directed therapy is needed 3, 1

Treatment Failure Management

  • The American Academy of Dermatology recommends assessing compliance, drug absorption, and potential reinfection sources if initial therapy fails 3
  • The British Association of Dermatologists recommends continuing current therapy for an additional 2-4 weeks if clinical improvement occurs but mycology remains positive 3
  • The American College of Dermatology recommends switching to alternative oral agent: use itraconazole if terbinafine failed, or terbinafine if azole failed 3, 2

REFERENCES